State Lawmakers Call For FTC To Probe CVS Caremark

Law360, New York (May 7, 2009, 12:00 AM EDT) -- A group of state lawmakers has asked the Federal Trade Commission to investigate whether the 2007 merger that created CVS Caremark Corp. has led to fraudulent and anti-competitive conduct, hurting prescription drug consumers.

Sharon Anglin Treat, executive director of the National Legislative Association on Prescription Drug Prices, said in a letter to FTC Chairman Jon Leibowitz on Thursday that the combination of CVS, a pharmacy operator, and Caremark, a pharmacy benefit manager, created opportunities for the company to enrich itself at the expense of competition and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.